Understanding Iron: Promoting Its Safe Use in Patients With Chronic Kidney Failure Treated by Hemodialysis
- 1 June 2013
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 61 (6) , 992-1000
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI StudyThe American Journal of Medicine, 2012
- Effect of Uremia on Structure and Function of Immune SystemJournal of Renal Nutrition, 2012
- Iron Sucrose Promotes Endothelial Injury and Dysfunction and Monocyte Adhesion/InfiltrationAmerican Journal of Nephrology, 2011
- An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and miceJournal of Clinical Investigation, 2011
- Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survivalBMC Nephrology, 2010
- Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failureAmerican Journal of Physiology-Renal Physiology, 2010
- Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesBMC Medical Genomics, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Alternative activation of macrophagesNature Reviews Immunology, 2003